Publicación:
Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels

dc.contributor.authorEduardo Gotuzzo
dc.contributor.authorBetzabé Butrón
dc.contributor.authorCarlos Seas
dc.contributor.authorMary E. Penny
dc.contributor.authorR Ruiz
dc.contributor.authorG Losonsky
dc.contributor.authorClaudio F. Lanata
dc.contributor.authorSteven S. Wasserman
dc.contributor.authorEduardo Salazar
dc.contributor.authorJames B. Kaper
dc.date.accessioned2026-05-14T21:43:27Z
dc.date.issued1993
dc.description.abstractGroups of 122 Peruvian adults of low socioeconomic level (SEL) and 125 of high SEL received a randomly allocated 5 x 10(9)- or 5 x 10(8)-CFU dose of CVD 103-HgR live oral cholera vaccine or a placebo. The vaccine was well tolerated. Vibriocidal seroconversions occurred in 78% of high-SEL and 72% of low-SEL subjects who ingested the high dose and in 78 and 49%, respectively, of those who received the low dose.en_US
dc.identifier.doihttps://doi.org/10.1128/iai.61.9.3994-3997.1993
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19789
dc.language.isoeng
dc.publisherAmerican Society for Microbiology
dc.relation.ispartofurn:issn:0019-9567
dc.relation.ispartofseriesInfection and Immunity
dc.relation.issn0019-9567
dc.rightshttp://purl.org/coar/access_right/c_14cb
dc.subjectVibrio bacteria research studiesen_US
dc.titleSafety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levelsen_US
dc.typehttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.localArtículo de revista
dc.type.versionjournal
dspace.entity.typePublication

Archivos